Arix Bioscience Plc - Notice of Results
Notice of Interim Results
(“Arix” or the “Company”) (LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, will announce its interim results for the six months ended , on Tuesday ., :
Arix will publish a pre-recorded presentation on the same day, at , followed by a Q&A session accessible via conference call or webcast at . The webcast of the presentation will be available on the Company's investor relations website at .
For more information on Arix, please contact:
, Head of Investor Relations
+44 (0) 20 7290 1072
Mary Clark, ,
T: +44 (0) 20 3950 9144
is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
Quick facts: Arix Bioscience PLC
Market Cap: £143.12 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE